Aclaris Therapeutics (ACRS) EBIT (2014 - 2026)
Aclaris Therapeutics (ACRS) posted EBIT of -$24.24 million for Q2 2026, compared with -$18.41 million a year earlier.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) EBIT (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBIT at Aclaris Therapeutics was -$86.31 million; for FY2025, it came in at -$76.38 million.
- In prior years, Aclaris Therapeutics' EBIT was -$141.93 million in FY2024, -$97.36 million in FY2023, -$89.85 million in FY2022 and -$89.72 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBIT since Q4 2024.
- According to Business Quant data, EBIT for the three prior quarters was -$22.19 million (Q1 2026), -$22.73 million (Q4 2025) and -$17.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Aclaris Therapeutics | 638.89 Mn | 236.88 Mn | 1.29 Mn | -21.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -21.34 Mn |
| Jun 30, 2026 | -24.24 Mn |
| Mar 31, 2026 | -22.19 Mn |
| Dec 31, 2025 | -22.73 Mn |
| Sep 30, 2025 | -17.15 Mn |
| Jun 30, 2025 | -18.41 Mn |
| Mar 31, 2025 | -18.08 Mn |
| Dec 31, 2024 | -99.68 Mn |
| Sep 30, 2024 | -10.47 Mn |
| Jun 30, 2024 | -12.85 Mn |
| Mar 31, 2024 | -18.93 Mn |
| Dec 31, 2023 | -4.05 Mn |
| Sep 30, 2023 | -31.58 Mn |
| Jun 30, 2023 | -31.82 Mn |
| Mar 31, 2023 | -29.92 Mn |
| Dec 31, 2022 | -29.08 Mn |
| Sep 30, 2022 | -20.87 Mn |
| Jun 30, 2022 | -20.99 Mn |
| Mar 31, 2022 | -18.91 Mn |
| Dec 31, 2021 | -22.89 Mn |
API Access
Aclaris Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();